AUM$8.50B
Expense Ratio0.44%
NAV$172.29
Holdings254
InceptionFeb 5, 2001
Price Chart
Key Statistics
Previous Close
$170.87Day Range
$166.04$169.77
52-Week Range
$112.02$177.64
Avg Volume
1.7MDividend Yield
0.23%Expense Ratio
0.44%AUM
$8.50BShares Outstanding
49.1MSector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 89.22% |
| Netherlands | 3.02% |
| Denmark | 2.19% |
| United Kingdom | 1.49% |
| Canada | 0.66% |
| Germany | 0.62% |
| France | 0.53% |
| Switzerland | 0.51% |
| Ireland | 0.51% |
| Other | 0.25% |
| Singapore | 0.16% |
| Spain | 0.15% |
| China | 0.15% |
| Australia | 0.13% |
| Jersey | 0.12% |
| Belgium | 0.11% |
| Italy | 0.07% |
| Cayman Islands | 0.06% |
| Iceland | 0.04% |
| Taiwan (Province of China) | 0.01% |
Fund Information
- Issuer
- IShares
- Category
- Healthcare
- Subcategory
- Biotech
- Inception Date
- Feb 5, 2001
- Exchange
- NASDAQ
- Description
- The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Similar ETFs
The iShares Biotechnology ETF (IBB) is an exchange-traded fund issued by IShares that launched on Feb 5, 2001. It currently manages $8.50B in assets under management. The fund charges an expense ratio of 0.44%. The fund holds 254 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 50.2% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | GILD | GILEAD SCIENCES INC | 9.62% | 5,451,913 | $809.9M |
| 2 | VRTX | VERTEX PHARMACEUTICALS INC | 9.38% | 1,582,225 | $789.8M |
| 3 | AMGN | AMGEN INC | 8.86% | 1,985,954 | $745.6M |
| 4 | REGN | REGENERON PHARMACEUTICALS INC | 6.80% | 741,512 | $572.5M |
| 5 | ALNY | ALNYLAM PHARMACEUTICALS INC | 3.64% | 950,893 | $306.5M |
| 6 | INSM | INSMED INC | 2.63% | 1,541,126 | $221.7M |
| 7 | ARGX | ARGENX SE ADR | 2.62% | 296,595 | $220.3M |
| 8 | BIIB | BIOGEN INC | 2.40% | 1,073,173 | $202.2M |
| 9 | NTRA | NATERA INC | 2.27% | 962,452 | $191.5M |
| 10 | UTHR | UNITED THERAPEUTICS CORP | 1.94% | 304,377 | $163.1M |
| 11 | ONC | BEONE MEDICINES AG | 1.92% | 529,864 | $161.8M |
| 12 | MRNA | MODERNA INC | 1.66% | 2,539,819 | $139.6M |
| 13 | INCY | INCYTE CORP | 1.62% | 1,423,009 | $136.6M |
| 14 | ILMN | ILLUMINA INC | 1.58% | 1,088,321 | $133.2M |
| 15 | RVMD | REVOLUTION MEDICINES INC | 1.42% | 1,211,340 | $119.8M |
Page 1 of 6
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | -2.24% | — | ||
| 1W | -1.21% | — | ||
| 1M | -0.69% | — | ||
| 3M | +0.86% | — | ||
| 6M | +21.43% | — | ||
| YTD | +1.11% | — | ||
| 1Y | +27.28% | — | ||
| 3Y | +36.29% | — | ||
| 5Y | +8.79% | — |
Moving Averages
20-Day MA
$172.67
Below 20-Day MA50-Day MA
$172.66
Below 50-Day MA200-Day MA
$150.17
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$177.64
Current Price
$167.07
52-Week Low
$112.02
$112.02$177.64
Current Yield
0.23%
Annual Dividend
$0.4495
Frequency
4x/year
Last Ex-Date
Dec 16, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $0.1831 | Dec 19, 2025 |
| Sep 16, 2025 | $0.0828 | Sep 19, 2025 |
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Dec 17, 2024 | $0.0624 | Dec 20, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
| Dec 20, 2023 | $0.1240 | Dec 27, 2023 |
| Sep 26, 2023 | $0.1532 | Oct 2, 2023 |
| Jun 7, 2023 | $0.0062 | Jun 13, 2023 |
| Mar 23, 2023 | $0.0646 | Mar 29, 2023 |
| Dec 13, 2022 | $0.1014 | Dec 19, 2022 |
| Sep 26, 2022 | $0.1586 | Sep 30, 2022 |
| Jun 9, 2022 | $0.0305 | Jun 15, 2022 |
| Mar 24, 2022 | $0.1176 | Mar 30, 2022 |
| Dec 13, 2021 | $0.0413 | Dec 17, 2021 |
| Sep 24, 2021 | $0.1244 | Sep 30, 2021 |
| Jun 10, 2021 | $0.0232 | Jun 16, 2021 |
| Mar 25, 2021 | $0.1311 | Mar 31, 2021 |
| Dec 14, 2020 | $0.0655 | Dec 18, 2020 |
| Sep 23, 2020 | $0.0632 | Sep 29, 2020 |
Dividend Payments Over Time
Category Comparison
| Metric | IBB | Healthcare(223 ETFs) | Biotech(39 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.44% | 0.60% | 0.84% |
| AUM | $8.50B | $1.25B | $1.62B |
| Dividend Yield | 0.23% | 2.75% | 14.38% |
| Avg Volume | 1.7M | 769.9K | 1.3M |
| Holdings | 254 | 182 | 67 |
| Performance | |||
| 1-Month Return | — | -3.02% | -2.05% |
| 6-Month Return | +19.54% | +5.85% | +15.05% |
| YTD Return | +1.24% | +0.17% | +1.05% |
| 1-Year Return | +25.79% | +16.65% | +24.43% |
Compare with Another ETF
Search for an ETF to compare with IBB: